Artificial Intelligence across
the early stage value-chain for
Pharmaceutical Research & Drug Discovery

Border

Our mission is to revolutionize early-stage drug discovery and development by democratizing access to cutting-edge generative AI and advanced physics-based simulation technology. Through expert-driven informatics leveraging our highly modular and data-driven in silico platform, we enhance existing workflows, reduce costs and significantly boost success rates

Medvolt

The MedvoltR Advantage

Our AI-accelerated in silico platform - MedGraphR empowers the generation of novel insights through efficient and resource-optimized pipelines. These insights translate into tangible experimental results thus delivering a compelling value proposition

Interpretable & Data-centric AI

Interpretable & Data-centric AI

We use interpretable models, trained on carefully curated domain data. Our advanced user interface offers real-time visualization of outcomes across the drug discovery pipeline.

Affordable & Enterprise class

Affordable & Enterprise class

Our platform is designed to be affordable, modular and flexible, catering to the diverse needs of a broad range of clients.

Multi-Domain Expertise

Multi-Domain Expertise

Our formidable team comprises experts spanning bio-physics, chemistry, biology, big data, AI/ML, high-performance computing and cloud engineering.

Substantial evidence

Substantial evidence

All our modules and AI models are enhanced and perfected through rigorous experimental validation.

TECHNOLOGY

Technology towards innovation

Data Ocean
Unified Biomedical Data at Scale

We aggregate and curate vast multi-modal biomedical and biochemical datasets using human-in-the-loop AI. Our continuously updated, high-integrity data lake powers translational research and accelerates drug discovery with precision and reliability.

AI-Driven Drug Discovery
Generative AI Meets Molecular Science

Medvolt’s AI engine integrates generative models, NLP, transfer learning, and reinforcement learning to streamline in silico drug discovery. By combining proprietary datasets with domain expertise, we overcome traditional R&D bottlenecks to deliver faster, smarter results.

Modular & Scalable Platform
Plug-and-Play In Silico Workflows

Built for flexibility, our cloud-native platform enables scalable, secure, and user-friendly access to AI-powered simulations. Clients can build custom workflows, launch HPC experiments, and collaborate seamlessly—all from an intuitive interface.

Knowledge Graph Intelligence
Ontology-Powered Biomedical Insights

We transform unstructured biomedical data into a structured, ontology-driven knowledge graph with deep reasoning capabilities. This forms the backbone of our AI models, combining LLMs with curated domain knowledge to unlock actionable insights.

OUR PLATFORM - MedGraphR

Leverage our modules to move beyond serendipity in drug discovery

Drug Repurposing Platform

MedGraph - Rubie

Rubie module stands as a distinctive and versatile drug repurposing platform. Offering two distinct approaches, Rubie excels in both the repositioning of drugs and the identification of therapeutic targets for those drugs.

LEARN MORE
New Chemical Entity

MedGraph - Topaaz

Our rapid, enterprise-class platform combines advanced AI and physics-based molecular modeling techniques to expedite the development of novel chemical entities while ensuring a robust toxicology profile.

LEARN MORE
Knowledge Graph

MedGraph EDGE

We swiftly and accurately extract insights from an extensive array of data sources to provide compelling evidence for new predictions in drug discovery.

LEARN MORE
Molecular Dynamics

MedGraph - Oopal - FEP

Leverage proprietary physics-based methods for precise free energy simulations, accelerating accurate drug discovery and optimization.

LEARN MORE

OUR SOLUTIONS

Discover our comprehensive solutions configured & delivered in a customized way
to meet your specific operational needs

Discover our comprehensive solutions configured & delivered in a customized way to meet your specific operational needs

Small Molecule Drug Discovery

Small Molecule Drug Discovery

Our AI-driven in-silico platform accelerates small molecule drug discovery, generating novel compounds faster and more cost-effectively with optimal pharmacological profiles.

Large Molecule Drug Discovery

Large Molecule Drug Discovery

With a full-stack AI-powered platform, we explore even the uncharted chemical space to find potentially safe large molecules as therapies for a wide range of diseases.

Knowledge Curation

Knowledge Curation

Leverage Medvolt's Knowledge Curation services to unlock the power of curated data for groundbreaking discoveries in drug development and precision medicine.

Peptide Therapeutics

Peptide Therapeutics

We find the best binding, synthesizable, selective peptides with optimal physicochemical and pharmacological properties by meticulously combining cutting-edge in-silico and physics-based modelling methods.

NEWS & MEDIA COVERAGE

Explore the latest news and milestones as Medvolt transforms the future of drug discovery

Medvolt Joins NVIDIA Inception Program

Medvolt is proud to join the NVIDIA Inception Program, strengthening our AI-driven drug discovery and knowledge curation capabilities. Stay tuned as we push the boundaries of AI-powered R&D transformation.


SUBSCRIBE TO OUR NEWSLETTER

Get the latest updates & insights on biotech news, plus exclusive updates from us!

Why Medvolt

Accelerate Discovery

Medvolt's AI-powered platform cuts pre-clinical discovery time by 3x, reduces costs by 15x and lowers failure risk by 25%. Enhance your R&D efficiency with our in silico tools.

High-Throughput Data

Enrich your research with Medvolt's proprietary, gold-standard, high-throughput proprietary datasets. Our AI and NLP solutions deliver speed, precision and scalability.

Expert Collaboration

Our experienced, tech-driven team collaborates globally with leading pharma and biotech companies, ensuring impactful, scalable solutions.